全球開放式、一體化生物制藥能力和技術賦能平臺,專注于為全球生物制藥公司提供端到端研發服務的上市公司
藥(yao)(yao)明生(sheng)(sheng)(sheng)物(wu)(股(gu)票代碼:2269.HK)作為(wei)(wei)一(yi)家香港上市公(gong)(gong)司(si),是(shi)全(quan)(quan)球(qiu)開(kai)放(fang)式、一(yi)體化(hua)生(sheng)(sheng)(sheng)物(wu)制(zhi)藥(yao)(yao)能(neng)(neng)力(li)和技術(shu)賦能(neng)(neng)平(ping)臺。公(gong)(gong)司(si)為(wei)(wei)全(quan)(quan)球(qiu)生(sheng)(sheng)(sheng)物(wu)制(zhi)藥(yao)(yao)公(gong)(gong)司(si)和生(sheng)(sheng)(sheng)物(wu)技術(shu)公(gong)(gong)司(si)提供(gong)端到(dao)端研(yan)發(fa)服務,幫助任何(he)人、任何(he)公(gong)(gong)司(si)發(fa)現(xian)、開(kai)發(fa)及(ji)生(sheng)(sheng)(sheng)產(chan)(chan)(chan)(chan)生(sheng)(sheng)(sheng)物(wu)藥(yao)(yao),實現(xian)從(cong)概念(nian)到(dao)商(shang)業(ye)化(hua)生(sheng)(sheng)(sheng)產(chan)(chan)(chan)(chan)的(de)全(quan)(quan)過程(cheng),加(jia)速全(quan)(quan)球(qiu)生(sheng)(sheng)(sheng)物(wu)藥(yao)(yao)研(yan)發(fa)進程(cheng),降低研(yan)發(fa)成本,造福病患。截至2018年12月(yue)31日,在(zai)(zai)藥(yao)(yao)明生(sheng)(sheng)(sheng)物(wu)平(ping)臺上研(yan)發(fa)的(de)綜合(he)項目達205個(ge),包括97個(ge)處(chu)于臨(lin)床(chuang)前研(yan)究(jiu)階段(duan)(duan),94個(ge)在(zai)(zai)臨(lin)床(chuang)早期(qi)(qi)(I期(qi)(qi),II期(qi)(qi))階段(duan)(duan),13個(ge)在(zai)(zai)后期(qi)(qi)臨(lin)床(chuang)(III期(qi)(qi))以及(ji)1個(ge)在(zai)(zai)商(shang)業(ye)化(hua)生(sheng)(sheng)(sheng)產(chan)(chan)(chan)(chan)階段(duan)(duan)。預計到(dao)2022年,公(gong)(gong)司(si)在(zai)(zai)中國、愛爾蘭、新加(jia)坡、美(mei)國規劃的(de)生(sheng)(sheng)(sheng)物(wu)制(zhi)藥(yao)(yao)生(sheng)(sheng)(sheng)產(chan)(chan)(chan)(chan)基地合(he)計產(chan)(chan)(chan)(chan)能(neng)(neng)約22萬升,這將有力(li)促使公(gong)(gong)司(si)通過健全(quan)(quan)強大的(de)全(quan)(quan)球(qiu)供(gong)應鏈網絡為(wei)(wei)客戶提供(gong)符合(he)全(quan)(quan)球(qiu)質量(liang)標準的(de)生(sheng)(sheng)(sheng)物(wu)藥(yao)(yao)。
藥(yao)明生物(wu)是全(quan)(quan)(quan)球開放式、一(yi)體(ti)化生物(wu)制(zhi)藥(yao)能(neng)(neng)力和(he)技術賦能(neng)(neng)平(ping)臺。公(gong)司為全(quan)(quan)(quan)球生物(wu)制(zhi)藥(yao)公(gong)司和(he)生物(wu)技術公(gong)司提供端(duan)到(dao)端(duan)研(yan)發(fa)服務,幫助任何人、任何公(gong)司發(fa)現、開發(fa)及生產生物(wu)藥(yao),實現從概(gai)念到(dao)商業化生產的(de)全(quan)(quan)(quan)過程。公(gong)司通過高(gao)質量、一(yi)體(ti)化服務賦能(neng)(neng)全(quan)(quan)(quan)球客戶,提高(gao)研(yan)發(fa)效率,降(jiang)低研(yan)發(fa)成本,進一(yi)步加速生物(wu)藥(yao)研(yan)發(fa)進程。